Precipio, Inc. stock is down -9.08% since 30 days ago. The next earnings date is Dec 12, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 9 November’s closed higher than October.
Precipio, Inc. provides diagnostic blood cancer testing services in the United States. The company sells ICE-COLD-PCR technology kits to bio-pharma customers. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment.